70 related articles for article (PubMed ID: 3264552)
1. Killing of virus-induced thymic lymphoma cells obtained from primary and early transfers by activated macrophages.
Boteach D; Gallily R
Isr J Med Sci; 1988; 24(9-10):518-21. PubMed ID: 3264552
[TBL] [Abstract][Full Text] [Related]
2. Characterization of macrophage recognition and killing of SV40-transformed tumor cells that are "resistant" or "susceptible" to contact-mediated killing.
Chapes SK; Duffin D; Paulsen AQ
J Immunol; 1988 Jan; 140(2):589-96. PubMed ID: 2826595
[TBL] [Abstract][Full Text] [Related]
3. In vivo antigenic modification of tumor cells. III. Metastatic thymic lymphoma specifically infected by thymotropic retrovirus.
Iglehart JD; Weinhold KJ; Huper G; Thiel K; Bolognesi DP
J Natl Cancer Inst; 1981 Jul; 67(1):123-30. PubMed ID: 6265678
[TBL] [Abstract][Full Text] [Related]
4. Macrophage-mediated in vitro sensitization of lymphocytes. II. The detection of neo-antigens on transformed lymphocytes and passages of normal fibroblasts.
Treves AJ; Declève A; Lieberman M; Feldman M; Kaplan HS
J Immunol; 1978 Jun; 120(6):1947-51. PubMed ID: 659886
[TBL] [Abstract][Full Text] [Related]
5. Immunoadjuvant effects of Blastomyces dermatitidis against EL 4 lymphoma in C57BL/6J mice.
McDaniel LS; Cozad GC
J Natl Cancer Inst; 1982 Dec; 69(6):1337-42. PubMed ID: 6958909
[TBL] [Abstract][Full Text] [Related]
6. Characterization of RFM mouse T lymphocyte anti-oncofetal antigen immunity in apparent tumor-free, long-term survivors of sublethal X-irradiation by limiting dilution T lymphocyte cloning.
Rohrer JW; Culpepper C; Barsoum AL; Coggin JH
J Immunol; 1995 Mar; 154(5):2266-80. PubMed ID: 7868899
[TBL] [Abstract][Full Text] [Related]
7. Antitumor and immunotherapeutic effects of activated invasive T lymphoma cells that display short-term interleukin 1alpha expression.
Voronov E; Weinstein Y; Benharroch D; Cagnano E; Ofir R; Dobkin M; White RM; Zoller M; Barak V; Segal S; Apte RN
Cancer Res; 1999 Mar; 59(5):1029-35. PubMed ID: 10070959
[TBL] [Abstract][Full Text] [Related]
8. The binding of BCG-activated macrophages to tumor targets stimulates secretion of cytolytic factor.
Johnson WJ; Whisnant CC; Adams DO
J Immunol; 1981 Nov; 127(5):1787-92. PubMed ID: 6795261
[TBL] [Abstract][Full Text] [Related]
9. Differences in the sensitivities of murine metastatic lymphoma/lymphosarcoma variants to macrophage-mediated cytolysis and/or cytostasis.
Miner KM; Nicolson GL
Cancer Res; 1983 May; 43(5):2063-7. PubMed ID: 6687559
[TBL] [Abstract][Full Text] [Related]
10. Activation of macrophage tumoricidal activity by photodynamic treatment in vitro--indirect activation of macrophages by photodynamically killed tumor cells.
Reiter I; Schwamberger G; Krammer B
J Photochem Photobiol B; 1999 Jun; 50(2-3):99-107. PubMed ID: 10515075
[TBL] [Abstract][Full Text] [Related]
11. Recognition and lysis of altered-self cells by macrophages. I. Modification of target cells by 2,4,6-trinitrobenzene sulphonic acid.
Kunin S; Gallily R
Immunology; 1983 Feb; 48(2):265-72. PubMed ID: 6600441
[TBL] [Abstract][Full Text] [Related]
12. Differences in cytotoxic effects of activated murine peritoneal macrophages and J774 monocytic cells on metastatic variants of B16 melanoma.
Miner KM; Klostergaard J; Granger GA; Nicolson GL
J Natl Cancer Inst; 1983 Apr; 70(4):717-24. PubMed ID: 6339778
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome.
Lay JD; Tsao CJ; Chen JY; Kadin ME; Su IJ
J Clin Invest; 1997 Oct; 100(8):1969-79. PubMed ID: 9329960
[TBL] [Abstract][Full Text] [Related]
14. T cells from naive mice suppress the in vitro cytotoxic response against endogenous Gross virus-induced tumor cells.
Tilkin AF; Gomard E; Begue B; Levy JP
J Immunol; 1984 Jan; 132(1):520-6. PubMed ID: 6228582
[TBL] [Abstract][Full Text] [Related]
15. Macrophages as effector cells of protective immunity in murine schistosomiasis. V. Variation in macrophage schistosomulacidal and tumoricidal activities among mouse strains and correlation with resistance to reinfection.
James SL; Skamene E; Meltzer MS
J Immunol; 1983 Aug; 131(2):948-53. PubMed ID: 6863937
[TBL] [Abstract][Full Text] [Related]
16. Enhanced lytic susceptibility of Ha-ras transformants after oncogene induction is specific to activated NK cells.
Johnson PW; Trimble WS; Hozumi N; Roder JC
J Immunol; 1987 Jun; 138(11):3996-4003. PubMed ID: 3495578
[TBL] [Abstract][Full Text] [Related]
17. Newcastle disease virus activates macrophages for anti-tumor activity.
Schirrmacher V; Bai L; Umansky V; Yu L; Xing Y; Qian Z
Int J Oncol; 2000 Feb; 16(2):363-73. PubMed ID: 10639582
[TBL] [Abstract][Full Text] [Related]
18. T cell-macrophage cognate interaction in the activation of macrophage effector function by Th2 cells.
Stout RD; Suttles J
J Immunol; 1993 Jun; 150(12):5330-7. PubMed ID: 8515061
[TBL] [Abstract][Full Text] [Related]
19. Gene expression and tumor cell escape from host effector mechanisms in murine large cell lymphoma.
LaBiche RA; Yoshida M; Gallick GE; Irimura T; Robberson DL; Klostergaard J; Nicolson GL
J Cell Biochem; 1988 Apr; 36(4):393-403. PubMed ID: 3379107
[TBL] [Abstract][Full Text] [Related]
20. IL-2 enhances standard IFNgamma/LPS activation of macrophage cytotoxicity to human ovarian carcinoma in vitro: a potential for adoptive cellular immunotherapy.
Han X; Wilbanks GD; Devaja O; Ruperelia V; Raju KS
Gynecol Oncol; 1999 Nov; 75(2):198-210. PubMed ID: 10525372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
